Skip to main content
Equibles

EP Wealth Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1540569 TORRANCE, CA
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,483,981
+$627,216 QoQ
Shares Held
9,027
+4.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EP Wealth Advisors, LLC holds $18,108,847 across 26 Biotechnology names. VRTX ranks #1 (24.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		9,027 $4,483,981
2 ARWR
Arrowhead Pharmaceuticals, Inc.
 38,135 $3,108,383
3 JAZZ
Jazz Pharmaceuticals plc
 6,385 $1,538,593
4 EXEL
Exelixis, Inc.
 23,865 $1,298,494
5 INCY
Incyte Corp
 10,863 $1,231,429
6 BNTX
BioNTech SE
 12,723 $1,183,875
7 REGN
Regeneron Pharmaceuticals, Inc.
 1,301 $811,225
8 HALO
Halozyme Therapeutics, Inc.
 8,761 $685,723

All Filings in VRTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,483,981 9,027
2026-03-31 $3,856,765 8,637
2025-12-31 $4,055,758 8,946
2025-06-30 $4,866,036 10,930
2025-03-31 $2,641,784 5,449
2024-12-31 $2,592,582 6,438
2024-09-30 $2,396,557 5,153
2024-06-30 $2,300,946 4,909
2024-03-31 $1,968,409 4,709
2023-12-31 $1,835,887 4,512
2023-09-30 $1,804,422 5,189
2023-06-30 $3,269,595 9,291